Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Matchar

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Health Services Research|August 31, 2000
Can continuous quality improvement be assessed using randomized trials? [see comment]G Samsa, D Matchar
Clinical Performance and Quality Health Care|June 7, 1995
Cost-effectiveness models of clinical trials of new pharmaceuticals for AIDS-related Pneumocystis carinii pneumonia: are they helpful to policy makers?C L Bennett, E Oddone, D Matchar
Annals of Internal Medicine|September 15, 1994
Management of atrial fibrillationD Matchar, D McCrory, E L Pritchett
Family Practice Research Journal|June 1, 1991
Cost-effectiveness evaluation of measles immunization strategies on a college campusD M Shlian, D Matchar, G B Seymann
Stroke|August 1, 1992
Measurement of motor recovery after stroke. Outcome assessment and sample size requirementsP W Duncan, L B Goldstein, D Matchar, et al.
Pharmacoeconomics|June 3, 1999
Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark IIG Samsa, D Edelman, M L Rothman, et al.
Chest|February 1, 1996
Cost-effectiveness of collecting routine cytologic specimens during fiberoptic bronchoscopy for endoscopically visible lung tumorJ A Govert, J M Kopita, D Matchar, et al.
Cancer|May 1, 1996
Cost-effective models for flutamide for prostate carcinoma patients: are they helpful to policy makers?C L Bennett, D Matchar, D McCrory, et al.
Chest|February 7, 2001
Managing oral anticoagulant therapyJ Ansell, J Hirsh, J Dalen, et al.
Stroke|April 1, 1997
Health status of individuals with mild strokeP W Duncan, G P Samsa, M Weinberger, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Health Services Research|August 31, 2000
Can continuous quality improvement be assessed using randomized trials? [see comment]G Samsa, D Matchar
Clinical Performance and Quality Health Care|June 7, 1995
Cost-effectiveness models of clinical trials of new pharmaceuticals for AIDS-related Pneumocystis carinii pneumonia: are they helpful to policy makers?C L Bennett, E Oddone, D Matchar
Annals of Internal Medicine|September 15, 1994
Management of atrial fibrillationD Matchar, D McCrory, E L Pritchett
Family Practice Research Journal|June 1, 1991
Cost-effectiveness evaluation of measles immunization strategies on a college campusD M Shlian, D Matchar, G B Seymann
Stroke|August 1, 1992
Measurement of motor recovery after stroke. Outcome assessment and sample size requirementsP W Duncan, L B Goldstein, D Matchar, et al.
Pharmacoeconomics|June 3, 1999
Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark IIG Samsa, D Edelman, M L Rothman, et al.
Chest|February 1, 1996
Cost-effectiveness of collecting routine cytologic specimens during fiberoptic bronchoscopy for endoscopically visible lung tumorJ A Govert, J M Kopita, D Matchar, et al.
Cancer|May 1, 1996
Cost-effective models for flutamide for prostate carcinoma patients: are they helpful to policy makers?C L Bennett, D Matchar, D McCrory, et al.
Chest|February 7, 2001
Managing oral anticoagulant therapyJ Ansell, J Hirsh, J Dalen, et al.
Stroke|April 1, 1997
Health status of individuals with mild strokeP W Duncan, G P Samsa, M Weinberger, et al.
Pageof 2